
第10åïŒmRNAãã¯ãããžãŒã¯äººé¡ã®ããã«çºæããããšããã®ã¯æ¬ºçã«æºã¡ã䞻匵ã§ãã
COVID-19ã®æ¬ºçãè§£ãïŒmRNAãã¯ãããžãŒã¯ãçåœã®æå·ã§ãããDNAãæžããããšã§ç¥ã«ãªãããšããç·ãã¡ã«ãã£ãŠçã¿åºããã
ã«ã¬ã³ã»ãã³ã°ã¹ãã³
11æ4æ¥
å èšäºã¯ãã¡ãã
SARS-CoV-2ããŠã€ã«ã¹ããããã«ææããã¹ãã€ã¯ã¿ã³ãã¯è³ªãçæããããã«é»æ°æ³³åmRNAæè¡ãå¿ èŠãšãããšãã蚌æ ã¯ããã®ã ãããïŒ
ã¯ãããããŸãããDNAãæžãæãããããã«mRNAé åã现èã«ææãããã¹ãã€ã¯ã»ã¿ã³ãã¯è³ªã®ãããªæ°ããéºäŒç©è³ªãäœãåºãã«ã¯ãé»åæ©åšã®äœ¿çšãäžå¯æ¬ ã§ããmRNAãã¯ãããžãŒã¯ã现èå ã人äœå ã«é»ç£å Žã宿ãèœåãå¯èœã«ããããã«ãã£ãŠmRNAç§åŠè ããçåœã®ã³ãŒããæžããã人é¡ãšãã¹ãŠã®çåœäœã«å¯ŸããŠç¥ã®åãæã€ãã®ããã«æ¯ãèãããšãã§ããããã«ããã®ã§ãã

SARS-CoV-2ããŠã€ã«ã¹ãã¯ãã¡ã©æ©èœç²åŸåmRNAæè¡çç©å µåšã§ããã ãã§ãªããã©ã«ãã»ããªãã¯å士èªèº«ã®2016幎PNASè«æã«ãããšãããªãã¯å士ã¯mRNA黿°æ³³åæè¡ã䜿ã£ãŠãSARS-CoV-2ã®æ©èœç²åŸåmRNAé åã现èã«ææãããŠææçްèããããªãªã³ïŒã¹ãã€ã¯ã¿ã³ãã¯è³ªïŒãçç£ããŠããŸãã
Ralph Baricã®è«æããã®æç²
"SARS-CoVææã¯ããŒã³ãé³åãšããŠãWIV1-CoVã®å®å
šé·ææã¯ããŒã³ãèšèšã»åæãã»ã»ã»çްèã«é»æ°ç©¿åããŠè€è£œèœåã®ããåå«ãŠã€ã«ã¹ãæåºãã "ãšããã

åå«ïŒãŸãã¯ããªãªã³ïŒã¯ãSARS-CoV-2ãšWIV1-CoVã®ã¹ãã€ã¯ã¿ã³ãã¯è³ªã§ããã

WIV1-CoVã¯ããªãªãžãã«ã®SARS-CoV-2é åã®ãŠã€ã«ã¹ãããç åæ§ã®é«ãã¹ãã€ã¯ã¿ã³ãã¯è³ªïŒåé§ã¹ãã€ã¯WIV1-2SPïŒãçæããããã«ãè質ããããã¯ãããžãŒã§ããŒãž/ã«ãã»ã«åãããmRNAã³ãŒãã§ãããEcoHealth Allianceã®Andrew Huffå士ãäžé¢ã«æåºãã蚌èšã®äžã§ãè質ãããã¯ãããžãŒïŒmRNA黿°æ³³åïŒã®åœ¹å²ãšåæ§ã«ãã®ããšã説æããŠããã°ãæçã ã£ãã ããã
ããªããå士ã®PNASè«æãããmRNAé åïŒãåæRNAãŠã€ã«ã¹ãïŒã现èã«ææããããã«é»æ°æ³³åãå¿ èŠã§ããããšãæãããªã ãã§ãªãã2021幎8æ23æ¥ã«FDAãæ¿èªããPFIZER瀟ã®BLAïŒbiological license applicationïŒã«mRNAãã¹ãã€ã¯ã¿ã³ãã¯è³ªã®ã³ãŒãã§ãããšæèšãããŠããã®ã§ããã

PFIZER瀟ã®FDAæ¿èªBLAã«ãããšããCOMIRNATYã®mRNAã¯...Wuhan-Hu-1ïŒWIV1ïŒå颿 ªç±æ¥ã®å®å šé·ã®SARS-CoV-2ã¹ãã€ã¯ç³ã¿ã³ãã¯è³ªãã³ãŒãããŠãããRNAé åã¯ã³ãã³æé©åãããŠãäºã€ã®ãããªã³å€ç°ïŒ2PïŒãå«ã¿ã... æé©ãªäžéäœäºåèå確èªïŒS-2PïŒãä¿èšŒãããŠããŸãããšèšèŒãããŠããŸãã

"COMIRNATYã®mRNAã¯ãSARS-CoV-2ã®ã¹ãã€ã¯ç³ã¿ã³ãã¯è³ªã§ããWIV1-2SPãã³ãŒãããŠããŸãã"- PFIZER瀟ã®FDA BLAç³è«ã2021幎8æ23æ¥ã«FDAæ¿èªæž
ããåºæ¬çãªããšã§ãããSARS-COV-2 mRNAãšWIV1-CoV RNAãäœãåºããã¹ãã€ã¯ã¿ã³ãã¯è³ªãã¯ãããšããšCOVID-19ã®åå ãšãªã£ãçç©å µåšã§ãããããããCOVID-19ã¹ãã€ã¯ã¿ã³ãã¯è³ªãã¯ãã¢ã¡ãªã«ãäžçäžã§ç æ°ãéå®³ãæ»ãåŒãèµ·ãããŠããAiçç©å µåšã®äžèŠçŽ ã«éããªãã
mRNAã¯ã¯ãã³ïŒããŒã¹ã¿ãŒãå«ãïŒã¯ããããã®Aiçç©å µåšãééãããWIV1-S-2Pã¹ãã€ã¯ã¿ã³ãã¯è³ªçç©å µåšã¯ãä»ã®CoV-S-2Pã¹ãã€ã¯ã¿ã³ãã¯è³ªçç©å µåšãšç±³åœç¹èš±0061185 A1å·ãå ±æããŠããã


ç¹èš±ãååŸããã2ã€ã®ãããªã³å€ç°ãïŒS-2PïŒã¯ãåæã§åçŸããèæ¯ãšçç¬ç ãŠã€ã«ã¹ã®æ¯çŽ ã§ããããšã¯æ¥µããŠéèŠã ã

FDAãæ¿èªããã¯ã¯ãã³ã«å«ãŸããæ¯çŽ ã¯ç¥çµæ¯ã«åé¡ãããŸããDARPAãšç±³åœæ å ±æ©é¢ã®ã¢ããã€ã¶ãŒã§ãããžã§ãŒã ã¹ã»ãžã§ã«ããŒãææã¯ã圌ã®çµç¹HDIACãéããŠãã¯ã¬ã€ãã»ã¹ããŒã¯ã»ããã·ã³ãšã³ãã©ã»ããã·ã³ã¯ç¥çµå µåšã«åé¡ããããšè¿°ã¹ãŠããã

ãžã§ãŒã ãºã»ãžã§ã«ããŒãã¯ããç¥çµå µåšã«ã¯ãççæ©èœãèªç¥æ©èœãäœäžãããè¬ç©ããæ»æãæŠéã®æ¬²æ±ãèœåã«åœ±é¿ãäžããææ ç¶æ ã®å€åãç¥çµçã®éº»çºãæ»ãèªçºããææ©æ¯çŽ ãªã©ãããããšæžããŠããã
ãžã§ã«ããŒãã¯ãè¬ç©ïŒãããã¯'ã¯ã¯ãã³'ïŒã¯ã身äœçã»èªç¥çèœåãäœäžãããæ»ææ§ãæŠéèœåãå«ãæ§ã
ãªææ
ç¶æ
ã墿žãããããã«äœ¿çšããããšãã§ãããšæèšããŠããŸããããããªãããããªãã¢ã¡ãªã«äººã¯äººé¡ãæãããã«å£çµããªãã£ãã®ã ããããšæã£ãŠãããªããããããã®çãã§ãã
ãžã§ã«ããŒãã¯ããã«ããããŸããŸãªã¬ãã«ã®ç
çç¶æ
ããããã¯æ»äº¡çããããã埮çç©ïŒãã¯ããªã¢ããŠã€ã«ã¹ãªã©ãéºäŒåçµã¿æãã®ããã€ãªããã¯ãçç©ãå«ãïŒãããã³æèŠãç¥èŠãèªç¥ãéåæ©èœãå€ããããã«äœ¿çšã§ããå€ãã®æè¡ããšè¿°ã¹ãŠããã
ãžã§ãŒã ãºã»ãžã§ã«ããŒãã¯ããã€ãªããã¯ãããéºäŒåçµã¿æãã®TECHNOLOGY-ORGANISMSã¯ããŠã€ã«ã¹ãšåŒã°ããããšããããšæèšããŠããŸããSARS-CoV-2ãŠã€ã«ã¹ã¯ããŠã€ã«ã¹ã§ã¯ãããŸãããSARS-CoV-2ã¯Aiå¯çè«ã§ããã倧éç Žå£å µåšã§ãããäžéšã¯çç©åŠã§ãããäžéšã¯ãã¯ãããžãŒïŒAiïŒã§ããã

ãããã®Aiçç©å µåšã¯ããã¹ãŠã®mRNA COVID-19ã¯ã¯ãã³ã«å«ãŸããŠããŸããçç©å µåšã¯ã¹ãã€ã¯ã¿ã³ãã¯è³ªãè質ãmRNAãšåŒã°ããäŸãã°ã"COMIRNATYã¯SARS-CoV-2ã®ãŠã€ã«ã¹ïŒSïŒç³ã¿ã³ãã¯è³ªïŒã¹ãã€ã¯ã¿ã³ãã¯è³ªïŒãã³ãŒãããmRNAã30mcgå«ãã§ããŸã "ãšéšãããŠããã®ã§ãã
åèåç»
1  ãã«ã¬ã³ã»ãã³ã°ã¹ãã³ãmRNAðã¯ãã¯ã¯ãã³ã§ã¯ãããŸãããã
ã«ã¬ã³ã»ãã³ã°ã¹ãã³
â @michisleepy (@michisleepy) June 18, 2023
ïœRNAðã¯ãã¯ã¯ãã³ã§ã¯ãããŸããã
ãã©ã³ã¹ã»ãã¥ãŒãããºã ïŒäººé¡çš®ã®æ¹é ïŒãç®çãšããããã€ãªæè¡ã®çç©å µåšã§ãã
ð·æéã®ããæã«ããã«åç»ïŒïŒïŒåïŒ https://t.co/YfXsMPrR88 pic.twitter.com/j0KO12mfil
åèèšäº
1  COVID-19ã®ãã³ãããã¯ã¯ãSARS-CoV-2ãŠã€ã«ã¹ããã®äºçš®ã«ãã£ãŠåŒãèµ·ãããããã®ã§ã¯ãªãã
COVID-19ã¯æ°çš®ã®Aiçç©å
µåšã§ãããäžéšã¯ãã¯ãããžãŒãäžéšã¯çç©åŠã§ããããããŠããã¯ç¥çã§ããã
2   COVID-19ã®æ¬ºçãè§£äœãããCOVID-19ãåŒãèµ·ãããã®ã¯mRNAãŠã€ã«ã¹ãSARs-CoV-2ã§ãããšããæ¬ºççãªäžççã·ããªãªãAndrew Huffåå£«ã®æå°ãšå°éå®¶ã®èšŒäººååãè£ä»ããŠããã